Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor
Background. Circulating microRNAs are appealing biomarkers to monitor several processes underlying cardiovascular diseases. Platelets are a major source for circulating microRNAs. Interestingly, the levels of specific microRNAs were reported to correlate with the level of platelet activation. The ai...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2016/3968206 |
id |
doaj-83210620bdc74e81aed39de974cf26ed |
---|---|
record_format |
Article |
spelling |
doaj-83210620bdc74e81aed39de974cf26ed2020-11-24T20:57:01ZengHindawi LimitedBioMed Research International2314-61332314-61412016-01-01201610.1155/2016/39682063968206Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to TicagrelorAnnarita Carino0Salvatore De Rosa1Sabato Sorrentino2Alberto Polimeni3Jolanda Sabatino4Gianluca Caiazzo5Daniele Torella6Carmen Spaccarotella7Annalisa Mongiardo8Antonio Strangio9Carol Filippis10Ciro Indolfi11Division of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyDivision of Cardiology, Department of Medical and Surgical Sciences, Magna Græcia University, 88100 Catanzaro, ItalyBackground. Circulating microRNAs are appealing biomarkers to monitor several processes underlying cardiovascular diseases. Platelets are a major source for circulating microRNAs. Interestingly, the levels of specific microRNAs were reported to correlate with the level of platelet activation. The aim of the present study was to test whether the treatment with the novel antiplatelet agent, ticagrelor, is associated with modulation in the levels of key platelet-derived microRNAs. Methods and Results. Patients were randomly selected from those participating in the SHIFT-OVER study, in which we had previously evaluated the effect of the therapeutic switch from clopidogrel to ticagrelor on platelet aggregation. Circulating levels of selected microRNAs were measured before and after the therapeutic switch from a dual antiplatelet therapy including acetylsalicylic acid (ASA) and clopidogrel to the more potent ticagrelor. Interestingly, the circulating levels of miR-126 (p=0.030), miR-223 (p=0.044), and miR-150 (p=0.048) were significantly reduced, while the levels of miR-96 were increased (p=0.038). No substantial differences were observed for the remaining microRNAs. Conclusions. Switching from a dual antiplatelet treatment with clopidogrel to ticagrelor is associated with significant modulation in the circulating levels of specific microRNAs. If confirmed in larger, independent cohorts, our results pave the way for the use of circulating microRNAs as biomarkers of platelets activity in response to specific pharmacological treatments.http://dx.doi.org/10.1155/2016/3968206 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Annarita Carino Salvatore De Rosa Sabato Sorrentino Alberto Polimeni Jolanda Sabatino Gianluca Caiazzo Daniele Torella Carmen Spaccarotella Annalisa Mongiardo Antonio Strangio Carol Filippis Ciro Indolfi |
spellingShingle |
Annarita Carino Salvatore De Rosa Sabato Sorrentino Alberto Polimeni Jolanda Sabatino Gianluca Caiazzo Daniele Torella Carmen Spaccarotella Annalisa Mongiardo Antonio Strangio Carol Filippis Ciro Indolfi Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor BioMed Research International |
author_facet |
Annarita Carino Salvatore De Rosa Sabato Sorrentino Alberto Polimeni Jolanda Sabatino Gianluca Caiazzo Daniele Torella Carmen Spaccarotella Annalisa Mongiardo Antonio Strangio Carol Filippis Ciro Indolfi |
author_sort |
Annarita Carino |
title |
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor |
title_short |
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor |
title_full |
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor |
title_fullStr |
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor |
title_full_unstemmed |
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor |
title_sort |
modulation of circulating micrornas levels during the switch from clopidogrel to ticagrelor |
publisher |
Hindawi Limited |
series |
BioMed Research International |
issn |
2314-6133 2314-6141 |
publishDate |
2016-01-01 |
description |
Background. Circulating microRNAs are appealing biomarkers to monitor several processes underlying cardiovascular diseases. Platelets are a major source for circulating microRNAs. Interestingly, the levels of specific microRNAs were reported to correlate with the level of platelet activation. The aim of the present study was to test whether the treatment with the novel antiplatelet agent, ticagrelor, is associated with modulation in the levels of key platelet-derived microRNAs. Methods and Results. Patients were randomly selected from those participating in the SHIFT-OVER study, in which we had previously evaluated the effect of the therapeutic switch from clopidogrel to ticagrelor on platelet aggregation. Circulating levels of selected microRNAs were measured before and after the therapeutic switch from a dual antiplatelet therapy including acetylsalicylic acid (ASA) and clopidogrel to the more potent ticagrelor. Interestingly, the circulating levels of miR-126 (p=0.030), miR-223 (p=0.044), and miR-150 (p=0.048) were significantly reduced, while the levels of miR-96 were increased (p=0.038). No substantial differences were observed for the remaining microRNAs. Conclusions. Switching from a dual antiplatelet treatment with clopidogrel to ticagrelor is associated with significant modulation in the circulating levels of specific microRNAs. If confirmed in larger, independent cohorts, our results pave the way for the use of circulating microRNAs as biomarkers of platelets activity in response to specific pharmacological treatments. |
url |
http://dx.doi.org/10.1155/2016/3968206 |
work_keys_str_mv |
AT annaritacarino modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT salvatorederosa modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT sabatosorrentino modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT albertopolimeni modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT jolandasabatino modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT gianlucacaiazzo modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT danieletorella modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT carmenspaccarotella modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT annalisamongiardo modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT antoniostrangio modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT carolfilippis modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor AT ciroindolfi modulationofcirculatingmicrornaslevelsduringtheswitchfromclopidogreltoticagrelor |
_version_ |
1716789017732710400 |